INVITRO ANTIMICROBIAL ACTIVITY OF TIGEMONAM, A NEW ORALLY-ADMINISTERED MONOBACTAM

被引:4
作者
FUCHS, PC [1 ]
JONES, RN [1 ]
BARRY, AL [1 ]
机构
[1] CLIN MICROBIOL INST,TUALATIN,OR 97062
关键词
D O I
10.1128/AAC.32.3.346
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:346 / 349
页数:4
相关论文
共 12 条
[1]   QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH AZTREONAM, IMIPENEM, CEFTRIAXONE, CEFTAZIDIME, CEFTIZOXIME, CEFUROXIME, AND CEFONICID [J].
BARRY, AL ;
GAVAN, TL ;
JONES, RN ;
AYERS, LW ;
FUCHS, PC ;
GERLACH, EH ;
THORNSBERRY, C .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 7 (01) :83-87
[2]  
BARRY AL, 1985, REV INFECT DIS, V7, pS594
[3]   INVIVO EVALUATION OF TIGEMONAM, A NOVEL ORAL MONOBACTAM [J].
CLARK, JM ;
OLSEN, SJ ;
WEINBERG, DS ;
DALVI, M ;
WHITNEY, RR ;
BONNER, DP ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) :226-229
[4]   INVITRO ACTIVITY OF CARUMONAM (RO-17-2301), BMY-28142, AZTREONAM, AND CEFTAZIDIME AGAINST 7620 CONSECUTIVE CLINICAL BACTERIAL ISOLATES [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
AYERS, LW ;
GAVAN, TL ;
GERLACH, EH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (04) :345-349
[5]  
JACOBUS NV, 1982, ANTIMICROB AGENTS CH, V22, P821
[6]   THE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND DISK DIFFUSION SUSCEPTIBILITY TESTING OF CARUMONAM (RO 17-2301, AMA-1080), A NEW MONOBACTAM [J].
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C ;
FUCHS, PC ;
PACKER, RR .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (05) :608-618
[7]   METHOD FOR RELIABLE DETERMINATION OF MINIMAL LETHAL ANTIBIOTIC CONCENTRATIONS [J].
PEARSON, RD ;
STEIGBIGEL, RT ;
DAVIS, HT ;
CHAPMAN, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) :699-708
[8]   INVITRO EVALUATION OF TIGEMONAM, A NOVEL ORAL MONOBACTAM [J].
TANAKA, SK ;
SUMMERILL, RAS ;
MINASSIAN, BF ;
BUSH, K ;
VISNIC, DA ;
BONNER, DP ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) :219-225
[9]  
1987, M26P NAT COMM CLIN L
[10]  
[No title captured]